Previous Article | Next Article 
Applied and Environmental Microbiology, January 2006, p. 653-659, Vol. 72, No. 1
0099-2240/06/$08.00+0 doi:10.1128/AEM.72.1.653-659.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Prevalence and Virulence Factors of Escherichia coli Serogroups O26, O103, O111, and O145 Shed by Cattle in Scotland
M. C. Pearce,1,2
J. Evans,2
I. J. McKendrick,3
A. W. Smith,1,2
H. I. Knight,1,2
D. J. Mellor,4
M. E. J. Woolhouse,1
G. J. Gunn,2 and
J. C. Low2*
Centre for Tropical Veterinary Medicine, University of Edinburgh, Roslin, Midlothian EH25 9RG, United Kingdom,1
Animal Health Group, Scottish Agricultural College, West Mains Rd., Edinburgh EH9 3JG, United Kingdom,2
Biomathematics & Statistics Scotland (BioSS), James Clerk Maxwell Building, King's Buildings, Edinburgh EH9 3JZ, United Kingdom,3
Institute of Comparative Medicine, Faculty of Veterinary Medicine, University of Glasgow, 464 Bearsden Rd., Glasgow G61 1QH, United Kingdom4
Received 10 June 2005/
Accepted 2 November 2005

ABSTRACT
A national survey was conducted to determine the prevalence
of
Escherichia coli O26, O103, O111, and O145 in feces of Scottish
cattle. In total, 6,086 fecal pats from 338 farms were tested.
The weighted mean percentages of farms on which shedding was
detected were 23% for
E. coli O26, 22% for
E. coli O103, and
10% for
E. coli O145. The weighted mean prevalences in fecal
pats were 4.6% for
E. coli O26, 2.7% for
E. coli O103, and 0.7%
for
E. coli O145. No
E. coli O111 was detected. Farms with cattle
shedding
E. coli serogroup O26, O103, or O145 were widely dispersed
across Scotland and were identified most often in summer and
autumn. However, on individual farms, fecal shedding of
E. coli O26, O103, or O145 was frequently undetectable or the numbers
of pats testing positive were small. For serogroup O26 or O103
there was clustering of positive pats within management groups,
and the presence of an animal shedding one of these serogroups
was a positive predictor for shedding by others, suggesting
local transmission of infection. Carriage of
vtx was rare in
E. coli O103 and O145 isolates, but 49.0% of
E. coli O26 isolates
possessed
vtx, invariably
vtx1 alone or
vtx1 and
vtx2 together.
The carriage of
eae and
ehxA genes was highly associated in
all three serogroups. Among
E. coli serogroup O26 isolates,
28.9% carried
vtx,
eae, and
ehxAa profile consistent
with
E. coli O26 strains known to cause human disease.

INTRODUCTION
Verocytotoxigenic
Escherichia coli (VTEC) strains are important
animal and human pathogens (
18,
23,
24,
29,
31,
39,
50). In
humans, VTEC strains are associated with illnesses ranging from
uncomplicated watery diarrhea to hemorrhagic colitis and potentially
fatal hemolytic uremic syndrome (
50). In North America, Japan,
and much of Europe, the VTEC serogroup usually associated with
human disease is serogroup O157 (
3,
22). However, in parts of
the southern hemisphere and continental Europe, other VTEC serogroups
are significant causes of human disease (
5,
10,
16,
28,
36,
46), especially VTEC O26, O103, O111, and O145, which are highly
associated with serious human infections (
4,
8,
43,
49,
50).
To date, isolation of non-O157 VTEC strains from human infections
has been uncommon in Scotland (
3) though VTEC serogroups O26,
O103, O111, and O145 are known to be carried by cattle (
47,
48,
50). This study was therefore undertaken to improve our
understanding of why non-O157 VTEC human infections are uncommon
in Scotland, and it had two major objectives. The first was
to conduct a national survey of the feces of Scottish cattle
to determine the prevalence of
E. coli serogroups O26, O103,
O111, and O145, which are potential VTEC strains. The second
objective was to screen bacterial isolates for genes encoding
enterohemolysin (
ehxA) and the virulence factors verocytotoxin
1 (
vtx1), verocytotoxin 2 (
vtx2), and intimin (
eae), which are
associated with strains causing human disease (
7,
14,
23,
27,
38,
50,
51).

MATERIALS AND METHODS
The farms used as the sampling frame for the study were chosen
from the 1997 Scottish Agricultural and Horticultural Census
data and randomly selected across all Scottish State Veterinary
Service animal health divisions (AHDs). A five-stage stratified
sampling plan was used to select farms to ensure that similar
numbers were included from each stratum and that strata were
sampled evenly over time between March 2002 and February 2004.
In each individual management group, sufficient fecal pats from
the sampled farms were tested to ensure an 80% chance of identifying
at least one positive pat when there was at least one shedding
animal within the group, assuming a mean within-farm shedding
prevalence of 7.8% on farms with positive-testing animals.
In total, tests were performed on 6,086 fecal pats collected from 338 farms, representing 3.5% of Scottish farms with cattle of older than 1 year of age that were store (i.e., young over-wintered animals) or were being finished for human consumption (2003 Scottish Agricultural and Horticultural Census). In the individual AHDs, from 51 to 59 farms and 912 to 1,142 fecal pats were sampled. In each season, with winter defined as December, January, and February, spring as March, April, and May, summer as June, July, and August, and autumn as September, October, and November, from 79 to 90 farms and 1,291 to 1,748 fecal pats were sampled. Fecal pat sampling was used because it was more practicable and ensured higher farmer compliance than sampling individual animals, and the results are thus representative of the Scottish cattle population and may be regarded as a proxy for animal level prevalence.
Bacterial isolation was conducted within 48 h of sampling with 1 g of feces from each sample preenriched in buffered peptone water and tested for the presence of E. coli serogroup O26, O103, O111, or O145 by use of immunomagnetic separation (IMS) and slide agglutination (35). All isolates provisionally identified as belonging to serogroup O26, O103, O111, or O145 were further tested by tube agglutination (32). All isolates with a positive tube agglutination result were submitted to The Laboratory of Enteric Pathogens, Health Protection Agency, Colindale, United Kingdom, and each isolate was biochemically identified as E. coli and the somatic O antigens were confirmed (2, 25).

RESULTS AND DISCUSSION
Farm-level data.
The mean percentages of farms with shedding cattle were estimated
using generalized linear mixed models (GLMMs) (
9,
34), with
binomial response terms and a logit link function. Data were
binary in form, so dispersion was set equal to 1. Farm cluster
and farm were fitted as random effects. Including AHD and season
as fixed effects, we used GLMMs to determine the impact of AHD
and season on the percentage of farms with shedding cattle and
to estimate the mean percentage of farms with shedding cattle
in each AHD and season. The GLMM parameter estimations were
converted into mean prevalences using both the transformed means
and random effects (
12). National farm-level prevalence figures
were derived from these estimates using data defining the number
of cattle farms with cattle over 1 year of age in each AHD.
A confidence interval for the farm-level
E. coli O111 mean prevalence
estimate was derived numerically, assuming that the log likelihood
ratio associated with an absence of positive pats in each AHD
would be well approximated by a
2 distribution. Confidence intervals
for serogroup O26, O103, and O145 means were derived by reweighing
output from the appropriate GLMM. The effect of AHD on the mean
prevalence of farms with cattle shedding
E. coli O145 was investigated
further using Fisher's exact test, and log-linear generalized
linear models were used to examine associations between
E. coli O26, O103, and O145 shedding results on farms (
44).
The observed number and percentage of farms positive for each serogroup are given in Table 1. The slight bias in the raw figure arises from the imbalance in the proportions of farms sampled from different AHDs relative to their full populations. The unbiased estimate of the mean percentage of farms in Scotland with cattle shedding E. coli serogroup O26 was 23% and was 22% for serogroup O103, which are results similar to the mean percentage of farms with cattle shedding E. coli O157 (22.8%) (45). In contrast, the mean percentage of farms with cattle shedding E. coli O145 (10%) was much lower.
View this table:
[in this window]
[in a new window]
|
TABLE 1. Numbers, observed percentages, and weighted mean percentages of farms with one or more store or finishing cattle shedding E. coli O26, O103, O111, or O145
|
Farms with cattle shedding
E. coli serogroup O26, O103, or O145
were widely dispersed across Scotland, with no statistical evidence
of regional differences in distribution, though shedding of
E. coli O145 was not detected on any farms in northeast AHDs
(Fig.
1). Season had a statistically significant effect (Fig.
2) on the mean percentages of farms with cattle shedding
E. coli serogroups O26 (
df=32 = 13.04;
P = 0.005) and O103 (
df=32 = 9.86;
P = 0.021), with positive results detected most frequently
in summer and autumn. A similar trend, but with no detectable
significant seasonal effect (
P = 0.44), was seen for the percentage
of farms with cattle shedding
E. coli O145.
Pat-level data, all farms.
For the whole of Scotland and within each AHD and season, the
distribution of the mean percentages of positive pats was approximated
using bootstrapping procedures (
13), as the skewed and potentially
bimodal distribution of the data resulted in poorly fitted GLMMs.
Each bootstrap exercise comprised 10,000 iterations of a two-stage
bootstrapping procedure. Within each iteration, farm clusters
were sampled with replacement, all farms were sampled within
each cluster, all management groups were sampled within each
farm, and pats were sampled with replacement in each management
group. The contribution of each sampled pat was weighted by
the inverse of the probability of selection from its management
group. Differences in the observed prevalences between AHDs
and seasons were each assessed by generating bootstrap samples
under the null hypothesis that the distributional properties
were the same over the entire data set (
13). The coexistence
of
E. coli O26, O103, or O145 strains in pats was analyzed using
log-linear models (
44).
The observed numbers and percentages of positive pats for each serogroup are given in Table 2 with a weighted, unbiased prevalence estimate and confidence interval. The bias in the raw figure arises because a larger percentage of pats were sampled from small management groups. The unbiased estimates of the pat-level prevalences of E. coli O26, O103, and O145 shedding by cattle over 1 year old across Scotland are 4.6%, 2.7%, and 0.7%, respectively. The mean pat-level prevalence of E. coli O26 detected by IMS is slightly more than one-half the prevalence of E. coli O157 (7.9%) previously described using similar methods (45). For all three serogroups the observed pat-level shedding was highest in summer and autumn, but across all farms, there was a statistically significant effect of season on only the mean percentage of pats positive for E. coli serogroup O103 (P = 0.04).
View this table:
[in this window]
[in a new window]
|
TABLE 2. Numbers, observed percentages, and weighted mean percentages of fecal pats shed by store or finishing cattle positive for E. coli O26, O103, O111, or O145
|
E. coli of serogroup O111 was not found in any samples, and
no upper confidence boundary is calculated for its prevalence
because any meaningful estimate would require information about
the clustering of positive samples. The absence of
E. coli O111
is consistent with the results of Scottish studies that used
IMS and also PCR with DNA hybridization techniques (
19,
20,
35), though
E. coli O111 has been previously isolated from cattle
(
26,
39,
47,
48) and there is a report of the isolation of this
serogroup from United Kingdom cattle in the early 1980s (
41).
On individual farms, fecal shedding of E. coli O26, O103, or O145 was usually undetectable or the number of positive pats was small (Fig. 3). However, the observed pat-level prevalences of shedding ranged widely between management groups on different farms. Within sampled groups, 0% to 83% of samples were positive for E. coli serogroup O26, 0% to 55% for serogroup O103, and 0% to 25% for serogroup O145. Clustering of shedding is thus evident within management groups, and the presence of an animal shedding serogroup O26 or O103 is a positive predictor for shedding by other cattle in the group. There is no statistical evidence that within a group the mean percentage of pats positive for serogroups O26, O103, or O145 is correlated with group size, and there is no strong evidence for a correlation between results showing the presence of the different E. coli serogroups O26, O103, and O145. These findings most likely suggest local transmission of infection, though an unknown highly localized risk factor cannot be excluded.
Pat-level data, farms with shedding cattle.
GLMMs with a binomial response distribution and a logit link
function were used to estimate the mean percentage of pats positive
for the subsets of positive farms, fitting farm cluster, farm,
and sample group as random effects. Incorporating AHD and season
as fixed effects, the models were used to determine the impact
of these factors on the mean percentage of positive pats.
In the farms with positive-testing animals, for each of serogroups O26, O103, and O145, there was no statistical evidence of any association between season or AHD and the mean percentage of positive pats. Intriguingly, our results thus indicated an increase in the number of farms with shedding cattle rather than a rise in the number of cattle shedding on farms where shedding is occurring. Other studies have reported that the percentage of farms with cattle shedding E. coli O157 is highest in summer and autumn (15, 40) or that the mean level of E. coli O157 shedding among cattle is highest in summer and autumn (17). The reasons for the apparent seasonality in shedding are not known. However, the pattern is reflected in the reported number of human cases of E. coli O157 infection, which also rise in summer (3, 42), though, so far as we are aware, no seasonal pattern of human infection with serogroup O26, O103, or O145 has been reported.
Molecular characterization of bacterial isolates.
The second study objective was to screen by multiplex PCR (33) all bacterial isolates for genes encoding enterohemolysin (ehxA) and the virulence factors verocytotoxin 1 (vtx1), verocytotoxin 2 (vtx2), and intimin (eae) that are associated with strains causing human disease (7, 14, 23, 27, 38, 50, 51). Carriage of the genes vtx1, vtx2, eae, and ehxA by E. coli serogroup O26, O103, and O145 isolates is shown in Table 3. A total of 122 (49.0%) E. coli O26 isolates carried vtx1, and 31 (12.5% of the total) of these also had vtx2. No E. coli O26 isolates carried vtx2 alone. A high percentage (83.9%) of serogroup O26 isolates possessed the eae gene, while approximately half (51.8%) carried ehxA. For E. coli serogroup O26 isolates there were 72 (28.9%) that carried vtx1, eae, and ehxA genes; these results are consistent with strains pathogenic to humans (7, 38, 51). Carriage of vtx genes was rare in serogroup O103 and O145 isolates. Only 2 of 168 (1.2%) serogroup O103 isolates were vtx positive: one carried vtx1, while the other possessed both vtx1 and vtx2. Among serogroup O145 isolates, 2 of 43 (4.7%) carried vtx genes: one carried vtx1 and the other vtx2.
View this table:
[in this window]
[in a new window]
|
TABLE 3. E. coli serogroup O26, O103, and O145 isolates and carriage of genes encoding verocytotoxin 1 (vtx1), verocytotoxin 2 (vtx2), intimin (eae), and enterohemolysin (ehxA)
|
Associations between isolate virulence factors were assessed
using contingency tables and Fisher's exact test (
44). For serogroup
O26 the percentage of
vtx-negative isolates with
eae (88.2%)
was not significantly different from the percentage of
vtx-positive
isolates with
eae (79.5%), but isolates with
eae were 12 times
more likely to carry
ehxA than isolates without
eae (
P< 0.001;
relative risk, 12.2; 95% confidence interval, 3.1 to 47.1).
In serogroups O103 and O145, carriage of
eae and
ehxA was also
common, and as has been previously noted (
6,
7), these genes
were highly associated (
P < 0.001 and
P = 0.001, respectively).
While both
eae and
ehxA encode putative virulence determinants,
the isolates from cattle that are
eae positive but
vtx negative
are generally regarded as atypical enteropathogenic
E. coli and may be less likely than VTEC to cause human disease (
37).
Most studies of non-O157 E. coli shedding by cattle detected strains by screening for verocytotoxin production or the presence of vtx genes and therefore present results biased to VTEC alone. The IMS technique is advantageous in being directed toward isolation of target serogroup strains irrespective of vtx gene carriage. Previous work has shown that, for the detection of VTEC O26, the IMS technique used is 2.5 times more sensitive than replica colony plating and DNA hybridization with vtx probes (21). IMS is also more sensitive for detection of E. coli O157 (11). We thus believe that the IMS technique is a valuable tool in the epidemiological study of VTEC and that our prevalence data with identification of low prevalences of VTEC O103, O111, and O145 in Scottish cattle more than 1 year old are more accurate than data from other estimates (1, 26, 35).
The scale of this study is larger than any described in the literature and establishes a benchmark for the prevalence of VTEC O26, O103, O111, and O145 carriage by cattle in Scotland and establishes that VTEC O26 strains are common and widely dispersed. However, the prevalence figures for each E. coli serogroup in this study should be regarded as minimum prevalence estimates as our sampling procedure is designed to give an 80% chance of detecting at least one positive pat from a group if one or more animals were shedding in that group. Additionally, the development and validation of indicator media could increase the sensitivity of detection and, therefore, the accuracy of prevalence estimates, as has happened with E. coli O157 studies.
VTEC serogroup O26 is important as a cause of human infection in central and southern Europe (46, 51), and in Italy this serogroup has surpassed E. coli O157 as the major cause of hemorrhagic colitis and hemolytic uremic syndrome (46). Though human disease associated with E. coli O26 has occurred in England (42), Scotland (3), and the Republic of Ireland (30), the number of serogroup O26 infections reported is very much smaller than for E. coli O157. There could be many reasons for the marked differences in the occurrence in United Kingdom of human infections caused by VTEC of E. coli O157 and O26 serogroups. However, the common finding in Scottish cattle of E. coli serogroup O26 isolates that are consistent with strains pathogenic to humans (7, 38, 51) is of significance. The results raise the issue of whether VTEC O26 strains from cattle pose a human health hazard and whether this serogroup may emerge to become a cause of human infections in Scotland. To investigate this further, our preliminary studies are focusing on a comparison of E. coli O26 isolates from humans and animals that have been collected from across Europe.

ACKNOWLEDGMENTS
We thank the late Henry Smith and Tom Cheasty, Laboratory of
Enteric Pathogens, Health Protection Agency, London, United
Kingdom, for their assistance in the serogrouping of isolates
and Simon Illingworth, IDG (UK) Ltd., Bury, United Kingdom,
for technical advice. We also acknowledge SEERAD for providing
data from the 2003 Scottish Agricultural and Horticultural Census.
The maps in Figure 1 incorporate data provided with the support of the ESRC and JISC and uses boundary material that is copyright of the Crown and the Post Office (source: the 1991 Census; Crown copyright; ESRC purchase).
This study was funded by Food Standards Agency, Scotland, and the International Partnership Research Award in Veterinary Epidemiology (IPRAVE), Epidemiology and Evolution of Enterobacteriaceae Infections in Humans and Domestic Animals, funded by the Wellcome Trust. The Scottish Agricultural College receives financial support from SEERAD. I.J.M. acknowledges the financial support of SEERAD project BSS/028/99.

FOOTNOTES
* Corresponding author. Mailing address: SAC Animal Health Group, Sir Stephen Watson Building, Bush Estate, Penicuik, Midlothian EH26 0PH, United Kingdom. Phone: 44 (0131) 535 3150/3317. Fax: 44 (0131) 535 3121. E-mail:
chris.low{at}sac.ac.uk 

REFERENCES
1 - Aktan, I., K. A. Sprigings, R. M. La Ragione, L. M. Faulkner, G. A. Paiba, and M. J. Woodward. 2004. Characterisation of attaching-effacing Escherichia coli isolated from animals at slaughter in England and Wales. Vet. Microbiol. 102:43-53.[CrossRef][Medline]
2 - Anonymous. 1993. Cowan and Steel's manual for the identification of medical bacteria. Cambridge University Press, Cambridge, United Kingdom.
3 - Locking, M., L. Allison, L. Rae, and M. Hanson. 2004. VTEC in Scotland 2003: enhanced surveillance and reference laboratory data. Scott. Cent. Infect. Environ. Health Wkly. Rep. 38:294-2974.
4 - Beutin, L., S. Zimmermann, and K. Gleier. 2001. Association between serotypes, virulence markers and disease in a group of 679 verocytotoxin-producing Escherichia coli (VTEC) strains isolated from human patients in Germany (1997-1999), p. 5-11. In G. Duffy, P. Garvey, J. E. Coia, Y. Wasteson, and D. A. McDowell (ed.), Epidemiology of verocytotoxigenic E. coli. Proceedings of the 5th Meeting Concerted Action CT98-3935: Verocytotoxigenic E. coli in Europe. Teagasc, Dublin, United Kingdom.
5 - Bielaszewska, M., J. M. Janda, K. Bláhová, J. Feber, V. Potuzník, and A. Soucková. 1996. Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic. Clin. Nephrol. 46:42-44.[Medline]
6 - Blanco, J. E., M. Blanco, M. P. Alonso, A. Mora, G. Dahbi, M. A. Coira, and J. Blanco. 2004. Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999. J. Clin. Microbiol. 42:311-319.[Abstract/Free Full Text]
7 - Boerlin, P., S. A. McEwen, F. Boerlin-Petzold, J. B. Wilson, R. P. Johnson, and C. L. Gyles. 1999. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37:497-503.[Abstract/Free Full Text]
8 - Brooks, J. T., D. Bergmire-Sweat, M. Kennedy, K. Hendricks, M. Garcia, L. Marengo, J. Wells, M. Ying, W. Bibb, P. M. Griffin, R. M. Hoekstra, and C. R. Friedman. 2004. Outbreak of Shiga toxin-producing Escherichia coli O111:H8 infections among attendees of a high school cheerleading camp. Clin. Infect. Dis. 38:190-198.[CrossRef][Medline]
9 - Brown, H., and R. Prescott. 1999. Applied mixed models in medicine. Wiley and Sons, Chichester, England.
10 - Caprioli, A., A. E. Tozzi, G. Rizzoni, and H. Karch. 1997. Non-O157 Shiga toxin-producing Escherichia coli infections in Europe. Emerg. Infect. Dis. 3:578.[Medline]
11 - Chapman, P. A., D. J. Wright, and C. A. Siddons. 1994. A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from bovine faeces. J. Med. Microbiol. 40:424-427.[Abstract/Free Full Text]
12 - Condon, J., G. Kelly, B. Bradshaw, and N. Leonard. 2004. Estimation of infection prevalence from correlated binomial samples. Prev. Vet. Med. 64:1-14.[CrossRef][Medline]
13 - Efron, B., and R. J. Tibshirani. 1998. An introduction to the bootstrap. Chapman and Hall-CRC Press, Boca Raton, Fla.
14 - Frankel, G., A. D. Phillips, I. Rosenshine, G. Dougan, J. B. Kaper, and S. Knutton. 1998. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 30:911-921.[CrossRef][Medline]
15 - Garber, L., S. Wells, L. Schroeder-Tucker, and K. Ferris. 1999. Factors associated with fecal shedding of verotoxin-producing Escherichia coli O157 on dairy farms. J. Food Prot. 62:307-312.[Medline]
16 - Gerber, A., H. Karch, F. Allerberger, H. M. Verweyen, and L. B. Zimmerhackl. 2002. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J. Infect. Dis. 186:493-500.[CrossRef][Medline]
17 - Hancock, D. D., T. E. Besser, D. H. Rice, D. E. Herriott, and P. I. Tarr. 1997. A longitudinal study of Escherichia coli O157 in fourteen cattle herds. Epidemiol. Infect. 118:193-195.[CrossRef][Medline]
18 - Janke, B. H., D. H. Francis, J. E. Collins, M. C. Libal, D. H. Zeman, D. D. Johnson, and R. D. Neiger. 1990. Attaching and effacing Escherichia coli infection as a cause of diarrhea in young calves. J. Amer. Vet. Med. Assoc. 196:897-901.
19 - Jenkins, C., H. Chart, T. Cheasty, G. A. Willshaw, M. C. Pearce, G. Foster, G. J. Gunn, H. R. Smith, G. Dougan, B. A. Synge, and G. Frankel. 2002. Verocytotoxin-producing Escherichia coli (VTEC) other than serogroup O157 from Scottish cattle. Vet. Rec. 151:58-60.[Free Full Text]
20 - Jenkins, C., M. C. Pearce, H. Chart, T. Cheasty, G. A. Willshaw, G. J. Gunn, G. Dougan, H. R. Smith, B. A. Synge, and G. Frankel. 2002. An eight-month study of a population of verocytotoxigenic Escherichia coli (VTEC) in a Scottish cattle herd. J. Appl. Microbiol. 93:944-953.[CrossRef][Medline]
21 - Jenkins, C., M. C. Pearce, A. W. Smith, H. I. Knight, D. J. Shaw, T. Cheasty, G. Foster, G. J. Gunn, G. Dougan, H. R. Smith, and G. Frankel. 2003. Detection of Escherichia coli serogroups O26, O103, O111 and O145 from bovine faeces using immunomagnetic separation and PCR/DNA probe techniques. Lett. Appl. Microbiol. 37:207-212.[CrossRef][Medline]
22 - Kaper, J. B., and A. D. O'Brien (ed.). 1998. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. ASM Press, Washington, D.C.
23 - Karmali, M. A. 1989. Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2:15-38.[Abstract/Free Full Text]
24 - Karmali, M. A., M. Petric, C. Lim, P. C. Fleming, G. S. Arbus, and H. Lior. 1985. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 151:775-782.[Medline]
25 - Kauffmann, A. F. 1944. Zur serologie der Coli-Gruppe. Acta Pathol. Microbiol. Scand. 21:20-45.
26 - Kobayashi, H., A. Miura, H. Hayashi, T. Ogawa, T. Endô, E. Hata, M. Eguchi, and K. Yamamoto. 2003. Prevalence and characteristics of eae-positive Escherichia coli from healthy cattle in Japan. Appl. Environ. Microbiol. 69:5690-5962.[Abstract/Free Full Text]
27 - Law, D. 2000. Virulence factors of Escherichia coli O157 and other Shiga toxin-producing E. coli. J. Appl. Microbiol. 88:729-745.[CrossRef][Medline]
28 - Lopez, E. L., M. Diaz, S. Grinstein, S. Devoto, F. Mendilaharzu, B. E. Murray, S. Ashkenazi, E. Rubeglio, M. Woloj, M. Vasquez, M. Turco, L. K. Pickering, and G. G. Cleary. 1989. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J. Infect. Dis. 160:469-475.[Medline]
29 - MacLeod, D. L., C. L. Gyles, and B. P. Willcock. 1991. Reproduction of edema disease of swine with purified Shiga-like toxin II variant. Vet. Pathol. 28:66-73.[Abstract]
30 - McMaster, C., E. A. Roch, G. A. Willshaw, A. Doherty, W. Kinnear, and T. Cheasty. 2001. Verocytotoxin-producing Escherichia coli serotype O26:H11 outbreak in an Irish crèche. Eur. J. Clin. Microbiol. Infect. Dis. 20:430-432.[CrossRef][Medline]
31 - Mohammad, A., J. S. M. Peiris, E. A. Wijewanta, S. Mahalingam, and G. Gunasekara. 1985. Role of verocytotoxigenic Escherichia coli in cattle and buffalo calf diarrhoea. FEMS Microbiol. Lett. 26:281-283.
32 - Ørskov, F., and I. Ørskov. 1984. Serotyping of Escherichia coli. Methods Microbiol. 14:43-112.
33 - Paton, A. W., and J. C. Paton. 1998. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. J. Clin. Microbiol. 36:598-602.[Abstract/Free Full Text]
34 - Payne, R. W. 2000. The guide to Genstat. Part 2: statistics. Lawes Agricultural Trust, Rothamstead, United Kingdom.
35 - Pearce, M. C., C. Jenkins, L. Vali, A. W. Smith, H. I. Knight, T. Cheasty, H. R. Smith, G. J. Gunn, M. E. J. Woolhouse, S. G. B. Amyes, and G. Frankel. 2004. Temporal shedding patterns and virulence factors of Escherichia coli serogroups O26, O103, O111, O145, and O157 in a cohort of beef calves and their dams. Appl. Environ. Microbiol. 70:1708-1716.[Abstract/Free Full Text]
36 - Prado, V., J. Martínez, C. Arellano, and M. Levine. 1997. Temporal variation of genotypes and serotypes of enterohemorrhagic E. coli isolated from Chilean children with asymptomatic infections or hemolytic uremic syndrome. Rev. Med. Chile 125:291-297.[Medline]
37 - Ramachandran, V., K. Brett, M. A. Hornitsky, M. Dowton, K. A. Bettelheim, M. J. Walker, and S. P. Djordjevic. 2003. Distribution of intimin subtypes among Escherichia coli isolates from ruminant and human sources. J. Clin. Microbiol. 41:5022-5032.[Abstract/Free Full Text]
38 - Schmidt, H., C. Geitz, P. I. Tarr, M. Frosch, and H. Karch. 1999. Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. J. Infect. Dis. 179:115-123.[CrossRef][Medline]
39 - Schoonderwoerd, M., R. C. Clarke, A. A. van Dreumel, and S. A. Rawluk. 1988. Colitis in calves: natural and experimental infection with a verotoxin-producing strain of Escherichia coli O111:NM. Can. J. Vet. Res. 52:484-487.[Medline]
40 - Schouten, J. M., M. Bouwknegt, A. W. van de Giessen, K. Frankena, M. C. M. De Jong, and E. A. M. Graat. 2004. Prevalence estimation and risk factors for Escherichia coli O157 on Dutch dairy farms. Prev. Vet. Med. 64:49-61.[CrossRef][Medline]
41 - Sherwood, D., D. R. Snodgrass, and G. H. K. Lawson. 1983. Prevalence of enterotoxigenic Escherichia coli in calves in Scotland and northern England. Vet. Rec. 113:208-212.[Abstract]
42 - Smith, H. R., B. Rowe, G. K. Adak, and W. J. Reilly. 1998. Shiga toxin (verocytotoxin)-producing Escherichia coli in the United Kingdom, p. 49-58. In J. B. Kaper and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. ASM Press, Washington, D.C.
43 - Sonntag, A.-K., R. Prager, M. Bielaszewska, W. Zhang, A. Fruth, H. Tschäpe, and H. Karch. 2004. Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany. J. Clin. Microbiol. 42:954-962.[Abstract/Free Full Text]
44 - Stokes, M. E., C. S. Davis, and G. G. Koch. 2000. Categorical data analysis using the SAS system. SAS Institute, Cary, N.C.
45 - Synge, B., and G. Paiba. 2000. Verocytotoxin-producing E. coli O157. Vet. Rec. 147:27.[Medline]
46 - Tozzi, A. E., A. Caprioli, F. Minelli, A. Gianviti, L. De Petris, A. Edefonti, G. Montini, A. Ferretti, T. De Palo, M. Gaido, and G. Rizzoni. 2003. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. Emerg. Infect. Dis. 9:106-108.[Medline]
47 - Wells, J. G., L. D. Shipman, K. D. Greene, E. G. Sowers, J. H. Green, D. N. Cameron, F. P. Downes, M. L. Martin, P. M. Griffin, S. M. Ostroff, M. E. Potter, R. V. Tauxe, and I. K. Wachsmuth. 1991. Isolation of Escherichia coli serotype O157:H7 and other Shiga-like-toxin-producing E. coli from dairy cattle. J. Clin. Microbiol. 29:985-989.[Abstract/Free Full Text]
48 - Wieler, L. H., E. Vieler, C. Erpenstein, T. Schlapp, H. Steinrück, R. Bauerfeind, A. Byomi, and G. Baljer. 1996. Shiga toxin-producing Escherichia coli strains from bovines: association of adhesion with carriage of eae and other genes. J. Clin. Microbiol. 34:2980-2984.[Abstract]
49 - Willshaw, G. A., T. Cheasty, H. R. Smith, S. J. O'Brien, and G. K. Adak. 2001. Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995-1998. J. Med. Microbiol. 50:135-142.[Abstract/Free Full Text]
50 - World Health Organization. 1998. Zoonotic non-O157 Shiga toxin-producing Escherichia coli (STEC). WHO/CSR/APH/98.8. World Health Organization, Geneva, Switzerland.
51 - Zhang, W.-L., M. Bielaszewska, A. Liesegang, H. Tschäpe, H. Schmidt, M. Bitzan, and H. Karch. 2000. Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains. J. Clin. Microbiol. 38:2134-2140.[Abstract/Free Full Text]
Applied and Environmental Microbiology, January 2006, p. 653-659, Vol. 72, No. 1
0099-2240/06/$08.00+0 doi:10.1128/AEM.72.1.653-659.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Nart, P., Naylor, S. W., Huntley, J. F., McKendrick, I. J., Gally, D. L., Low, J. C.
(2008). Responses of Cattle to Gastrointestinal Colonization by Escherichia coli O157:H7. Infect. Immun.
76: 5366-5372
[Abstract]
[Full Text]
-
Khanna, R., Waechter, L., Sargeant, J., Clark, W. F., Garg, A. X.
(2008). Environmental prevention of human disease from verocytotoxin-producing Escherichia coli. Nephrol Dial Transplant
23: 1819-1822
[Abstract]
[Full Text]
-
Foster, A. P., Otter, A., Barlow, A. M., Pearson, G. R., Woodward, M. J., Higgins, R. J.
(2008). Naturally occurring intestinal lesions in three alpacas (Vicugna pacos) caused by attaching and effacing Escherichia coli. Vet Rec.
162: 318-320
[Full Text]
-
Aktan, I., Carter, B., Wilking, H., La Ragione, R. M., Wieler, L., Woodward, M. J., Anjum, M. F.
(2007). Influence of geographical origin, host animal and stx gene on the virulence characteristics of Escherichia coli O26 strains. J Med Microbiol
56: 1431-1439
[Abstract]
[Full Text]
-
Aktan, I., La Ragione, R. M., Pritchard, G. C., Woodward, M. J.
(2007). Prevalence of attaching and effacing Escherichia coli serogroup O103 in orphan lambs on an open farm in eastern England. Vet Rec.
161: 386-387
[Full Text]
-
Hall, L. M., Evans, J., Smith, A. W., Pearce, M. C., Knight, H. I., Foster, G., Low, J. C., Gunn, G. J.
(2006). Sensitivity of an Immunomagnetic-Separation-Based Test for Detecting Escherichia coli O26 in Bovine Feces. Appl. Environ. Microbiol.
72: 7260-7263
[Abstract]
[Full Text]